Wiley Schedules Second Quarter 2023 Earnings Release and Conference Call

30 Nov 2022
Financial Statement
HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc. (NYSE: WLY), one of the world’s largest publishers and a global leader in scientific research and career-connected education, will release its second quarter 2023 results prior to market open on Wednesday, December 7, 2022. The Company has scheduled a conference call beginning at 10 am ET that day to discuss the results. The live audio webcast and presentation slides will be available at , or on Wiley’s Investor Relations website at investors.wiley.com. An archive of the webcast, presentation, and transcript will be available for a period of one year. US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. About Wiley Wiley is one of the world’s largest publishers and a global leader in scientific research and career-connected education. Founded in 1807, Wiley enables discovery, powers education, and shapes workforces. Through its industry-leading content, digital platforms, and knowledge networks, the company delivers on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.